Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bender

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
Journal of the American Chemical Society|October 20, 2023
Sequence-Defined Conjugated Oligomers in Donor-Acceptor DyadsHarrison A Mills, Samihat Rahman, Rachel Zigelstein, et al.
Gynecologic Oncology|April 19, 2015
A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group studyRobert L Coleman, Michael W Sill, Premal H Thaker, et al.
Cell|October 10, 2007
MiR-150 controls B cell differentiation by targeting the transcription factor c-MybChangchun Xiao, Dinis Pedro Calado, Gunther Galler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2009
T-lineage cells require the thymus but not VDJ recombination to produce IL-17A and regulate granulopoiesis in vivoEmily Smith, Sibylle von Vietinghoff, Matthew A Stark, et al.
Oncotarget|June 26, 2015
Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1Zoran Gatalica, Nurija Bilalovic, Juan P Palazzo, et al.
Gynecologic Oncology|April 9, 2014
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group studyRonald D Alvarez, Michael W Sill, Susan A Davidson, et al.
ACS Applied Materials & Interfaces|February 10, 2015
Assessing the potential roles of silicon and germanium phthalocyanines in planar heterojunction organic photovoltaic devices and how pentafluoro phenoxylation can enhance π-π interactions and device performanceBenoît H Lessard, Robin T White, Mohammad Al-Amar, et al.
Gynecologic Oncology|April 18, 2026
Identifying ovarian cancer with AI analysis of abdominal CT scansKatherine Sawaya, Margot Maraghe, Samantha Metzger, et al.
BMC Genomics|March 30, 2010
Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosisAlice Brockington, Paul R Heath, Hazel Holden, et al.
Cancer Letters|December 27, 2012
Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancerNiyati J Nadkarni, Koen De Geest, Traci Neff, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
Journal of the American Chemical Society|October 20, 2023
Sequence-Defined Conjugated Oligomers in Donor-Acceptor DyadsHarrison A Mills, Samihat Rahman, Rachel Zigelstein, et al.
Gynecologic Oncology|April 19, 2015
A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group studyRobert L Coleman, Michael W Sill, Premal H Thaker, et al.
Cell|October 10, 2007
MiR-150 controls B cell differentiation by targeting the transcription factor c-MybChangchun Xiao, Dinis Pedro Calado, Gunther Galler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2009
T-lineage cells require the thymus but not VDJ recombination to produce IL-17A and regulate granulopoiesis in vivoEmily Smith, Sibylle von Vietinghoff, Matthew A Stark, et al.
Oncotarget|June 26, 2015
Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1Zoran Gatalica, Nurija Bilalovic, Juan P Palazzo, et al.
Gynecologic Oncology|April 9, 2014
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group studyRonald D Alvarez, Michael W Sill, Susan A Davidson, et al.
ACS Applied Materials & Interfaces|February 10, 2015
Assessing the potential roles of silicon and germanium phthalocyanines in planar heterojunction organic photovoltaic devices and how pentafluoro phenoxylation can enhance π-π interactions and device performanceBenoît H Lessard, Robin T White, Mohammad Al-Amar, et al.
Gynecologic Oncology|April 18, 2026
Identifying ovarian cancer with AI analysis of abdominal CT scansKatherine Sawaya, Margot Maraghe, Samantha Metzger, et al.
BMC Genomics|March 30, 2010
Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosisAlice Brockington, Paul R Heath, Hazel Holden, et al.
Cancer Letters|December 27, 2012
Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancerNiyati J Nadkarni, Koen De Geest, Traci Neff, et al.
Pageof 26